COMMUNIQUÉS West-GlobeNewswire

CymaBay Reports Fourth Quarter and Fiscal Year End 2018 Financial Results and Provides Corporate Update
28/02/2019
Conference call and webcast today at 4:30p.m. ET NEWARK, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY) a clinical-stage biopharmaceutical company focused on developing therapies for [...]
ICU Medical, Inc. Announces Fourth Quarter 2018 Results
28/02/2019
SAN CLEMENTE, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care [...]
SI-BONE to Present at the Canaccord Genuity Musculoskeletal Conference
28/02/2019
SANTA CLARA, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a medical device company that is pioneering the minimally invasive surgical treatment of the sacroiliac joint with the iFuse [...]
Fulgent Genetics Reports Fourth Quarter and Full Year 2018 Financial Results
28/02/2019
Fourth Quarter 2018 Results : Revenue totals $5.7 million, growing 33% year over year Billable tests delivered total 6,408, growing 52% year over year GAAP loss of $935,000, or $0.05 per share Non-GAAP loss of $193,000 [...]
Radius Health Announces Fourth Quarter and Full-Year 2018 Operating Results
28/02/2019
TYMLOS® U.S. net sales continued to increase, reaching $34.4 million in the fourth quarter of 2018 and totaling $99.2 million for full-year 2018, exceeding the Company’s guidance of $95-98 million. Elacestrant’s Phase 3 [...]
KemPharm Reports Q4 and FY 2018 Results
28/02/2019
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET Development & Regulatory Highlights: Completed KP415 clinical and human abuse potential programs Received approval [...]
HealthEquity Sets Date to Announce Year-end Results
28/02/2019
Attend Investor Conference DRAPER, Utah, Feb. 28, 2019 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent HSA custodian, today announced that it plans to [...]
Mersana Therapeutics Announces Proposed Public Offering of Common Stock
28/02/2019
CAMBRIDGE, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (Nasdaq:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update
28/02/2019
SAN DIEGO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]
Harvard Bioscience Reports Strong Fourth Quarter and Year-End 2018 Results, and Issues 2019 Financial Guidance
28/02/2019
-Reports record Fourth Quarter GAAP and adjusted non-GAAP revenue of $33.9 million, a year-over-year increase of 56% and 24%, respectively- HOLLISTON, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. ( [...]
March is #ChildrensWishMonth - Help Grant More Heartfelt Wishes
28/02/2019
Donate today at ChildrensWish.ca/WishMonth TORONTO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Children’s Wish Foundation of Canada, the largest and only all-Canadian wish-granting charity, is kicking off #ChildrensWishMonth [...]
En mars, faites-les rêver! Participez au #MoisRevesdenfants et aidez encore plus d’enfants malades à réaliser leur plus grand rêve
28/02/2019
Faites un don à revesdenfants.ca/Moisrevesdenfants . MONTRÉAL, 28 févr. 2019 (GLOBE NEWSWIRE) -- La Fondation Rêves d’enfants, le plus grand et le seul organisme de bienfaisance entièrement canadien dédié à la [...]
Nuvectra® Reports Fourth Quarter and Full Year 2018 Financial Results
28/02/2019
Record Fourth Quarter & Full Year 2018 Algovita® Sales of $14.1 million and $47.1 million, Up 36% and 84% YoY Respectively PLANO, Texas, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a [...]
Foamix Reports Fiscal Year 2018 Financial Results and Provides Corporate Update
28/02/2019
Conference Call Scheduled for Friday, March 1 at 8:30am Eastern Time REHOVOT, Israel and BRIDGEWATER, N.J., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) (“Foamix Pharmaceuticals” or the “ [...]
G1 Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results
28/02/2019
Reported positive findings in all four randomized Phase 2 clinical trials of trilaciclib in 2018 Clinical program updates to be provided at Investor Day 2019 on March 6 Management to host webcast and conference call [...]
Diversicare Announces 2018 Fourth Quarter Results
28/02/2019
BRENTWOOD, Tenn., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR), a premier provider of long-term care services, today announced its results for the fourth quarter ended December [...]
Editas Medicine Announces Fourth Quarter and Full Year 2018 Results and Update
28/02/2019
EDIT-101 for LCA10 set to be first ever in vivo CRISPR medicine administered to patients with dosing expected in second half of 2019 Advancing potentially best-in-class engineered cell medicine for sickle cell disease [...]
Sturdy Memorial Hospital selects Cerner EHR for cutting-edge functionality
28/02/2019
ATTLEBORO, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Sturdy Memorial Hospital (SMH) is set to upgrade its current electronic health record (EHR) with a full suite of Cerner Millennium® acute, ambulatory and revenue cycle [...]
Flexion Therapeutics Reports Fourth-Quarter and Full-Year 2018 Financial Results
28/02/2019
Company reported net ZILRETTA ® (triamcinolone acetonide extended-release injectable suspension) sales of $22.5 million for full-year 2018 Since launch, 90% of target accounts have purchased or received samples of [...]

Pages